Investor profile
F-Prime Capital has backed 12 European tech companies across 15 funding rounds between 2016 and 2026, joining rounds totalling €679M. Most active in Healthtech and AI. Data as of 7 Aug 2026.
Also recorded as: F Prime Capital · F-Prime Capital Partners
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Leyden Labs | Netherlands | 1 | €124M |
| Charm Therapeutics | UK | 2 | €116M |
| Ota Insight | UK | 2 | €89M |
| Oviva | UK | 2 | €79M |
| Funnel | Sweden |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Leyden Labs | Series B | €124M | 2022-01 |
| Ota Insight | Series B | €71M | 2021-11 |
| Charm Therapeutics | Series B | €69M | 2025-09 |
| Oviva |
| 1 |
| €57M |
| Hercle | Italy | 1 | €52M |
| Castor | Netherlands | 1 | €38M |
| Peptone | UK | 1 | €37M |
| Proximie | UK | 1 | €32M |
| Pulmocide | UK | 1 | €28M |
| STS Digital | Switzerland | 1 | €25M |
| Castle | Sweden | 1 | €1.8M |
| Series C |
| €68M |
| 2021-09 |
| Funnel | Pre-Seed | €57M | 2021-10 |
| Hercle | Other | €52M | 2025-10 |
| Charm Therapeutics | Series A | €47M | 2022-06 |
| Castor | Series B | €38M | 2021-07 |
| Peptone | Other | €37M | 2022-06 |
| Proximie | Series B | €32M | 2021-04 |
